"AHA 2024: Muvalaplin shows promising Phase II results for elevated serum lipoprotein (a)" was originally created and ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip NDtm Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR ...

This robust expansion highlights the increasing demand for SDA in molecular diagnostics and research applications. SDA, an ...